In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates

Indian Journal of Medical Microbiology

Volumn 24, Issue 4, 2006, Pages 273-279

  Therese, K L ^a   Bagyalakshmi, R ^a   Madhavan, H N ^a   Deepa, P ^a  

^a VISION RESEARCH FOUNDATION   (India)

Author keywords

Agar dilution method; Amphotericin B; Antifungal susceptibility testing; Fluconazole; Ketoconazole; MIC

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; KETOCONAZOLE;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; CANDIDA KRUSEI; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CULTURE MEDIUM; DILUTION; EYE INFECTION; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; GROWTH INHIBITION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; YEAST;

EID: 33845936907     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.29386     Document Type: Article

References (21)

1. Thomas PA. Current perspective in ophthalmic mycoses. Clin Microbio Rev 2003;16:730-97.
2. Leck AK, Thomas PA, Hagan M, Kaliamurthy J, Ackuaku E, John M, et al. Aetiology of suppurative Corneal ulcer in Ghana and South India and epidemiology of fungal keratitis. Br J Ophthalmol 2002;86:1211-5.
3. Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The epidemiological features and laboratory results of fungal keratitis: A 10-year review at a referral eye care center in South India. Cornea 2002;2:555-9.
4. Jaeger EE, Carroll NM, Choudhury S, Dunlop AA, Towler HM, Matheson MM, et al. Rapid detection and identification of Candida, Aspergillus and Fusarium species in ocular samples using nested PCR. J Clin Microbiol 2001;38:2902-8.
5. Srinivasan M, Gonzales CA, George C, Cevallos V, Marcarenhus JM, Asokau B, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol 1997;81:965-71.
6. Ghannoum MA, Rex JH, Galgiani JN. Susceptibility testing of fungi: Current status of correlation in vitro data with clinical outcome. J Clin Microbiol 1996;34:489-95.
7. Wanger A, Mills K, Nelson PW, Rex JH. Comparison of E test and National Committee for Clinical Laboratory standards broth macro dilution method for antifungal susceptibility testing: Enhanced ability to detect amphotericin B resistant Candida isolates. Antimicrob agents Chemother 1995;39:2520-2.
8. Pfaller MA. CLSI Reference method for broth dilution antifungal susceptibility testing of conidium forming filamentous fungi; proposed standard 1997;18:16-9.
9. Yoshida T, Jono K, Okonogi K. Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compounds. Antimicrob Agents Chemother 1997;41:1349-51.
10. Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Oral ketoconazole in keratomycosis. Indian J Ophthalmol 1987;35:197-207.
11. Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy for mycotic keratitis. Mycoses 1988;31:271-9.
12. th ed. 2000. p. 711-36.
13. Makimura K, Suzuki T, Tamura T, Ikedo M, Hanazawa R, Takahashi Y, et al. Comparative evaluation of standard dilution method and commercial kit for frozen plate antifungal susceptibility testing of yeasts using 200 clinical isolates. Microbiol Immunol 2004;48:747-53.
14. Ghannoum MA, Ibrahim AS, Fu Y, Shafiq MC, Edwards JE Jr, Criddle RS. Susceptibility testing of Cryptococcus neoformans: A microdilution technique. J Clin Microbiol 1992;30:2881-6.
15. th ed. 2000. p. 788-98.
16. Narasimhan S, Madhavan HN, Therese KL. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine. Cornea 2002;21:203-5.
17. Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH. Micro dilution susceptibility testing of Amphotericin B, Itraconazole, Voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol 1999;37:3946-51.
18. Ramani R, Chaturvedi V. Proficiency testing program for clinical laboratories performing antifungal susceptibility testing of pathogenic yeast species J Clin Microbiol 2003;41:1143-6.
19. Davey KG, Holmes AD, Johnson EM, Szekeley A, Warnock DW. Comparative evaluation of broth micro dilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. J Clin Microbiol 1998;36:926-30.
20. Rex JH, Pfaller MA, Walsh TJ, Chaturvedi V, Espinel-Ingroff A, Ghannoum MA, et al. Antifungal susceptibility testing: Practical aspects and current challenges. Clin Microbiol Rev 2001;14:643-58.
21. Iyer RS, Pal RB, Patel RB, Banker DD. PCR based diagnosis of systemic fungal infections and sensitivity testing of fungal isolates. Indian J Med Microbiol 2002;20:160-2.